Multimodal approach for cervical esophageal carcinoma: role of neoadjuvant chemotherapy. (Record no. 23699335)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01441 a2200481 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516204512.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201406s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1791-7530 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Suzuki, Gen |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20140615 |
245 00 - TITLE STATEMENT | |
Title | Multimodal approach for cervical esophageal carcinoma: role of neoadjuvant chemotherapy. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Anticancer research |
Date of publication, distribution, etc. | Apr 2014 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1989-92 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Squamous Cell |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Chemoradiotherapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Esophageal Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoadjuvant Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Staging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prognosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tumor Burden |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yamazaki, Hideya |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ogo, Etsuyo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Abe, Toshi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Eto, Hidehiro |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Muraki, Koichiro |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hattori, Chikayuki |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Umeno, Hirohito |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nakashima, Tadashi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tanaka, Toshiaki |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nakamura, Satoaki |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yoshida, Ken |
773 0# - HOST ITEM ENTRY | |
Title | Anticancer research |
Related parts | vol. 34 |
-- | no. 4 |
-- | p. 1989-92 |
No items available.